Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases

Sofia Farkona, Antoninus Soosaipillai, Panagiota Filippou, Christos Liaskos, Dimitrios P. Bogdanos, Eleftherios P. Diamandis, Ivan M. Blasutig

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)

    Abstract

    Pancreatic autoantibodies (PABs) are detected in patients with inflammatory bowel disease (IBD). Their prevalence is higher in Crohn's disease (CrD) than in ulcerative colitis (UC). Glycoprotein 2 (GP2) and, more recently, CUB and zona pellucida-like domain-containing protein 1 (CUZD1) have been identified as target autoantigens of PAB. The clinical utility of CUZD1 autoantibodies has only recently been assessed by indirect immunofluorescence (IIF) assays. In this study, we developed and validated novel immunoassays for the detection of CUZD1 autoantibodies. Recombinant CUZD1 protein was utilized as a solid-phase antigen for the development of two immunoassays for the detection of IgG and IgA CUZD1 autoantibodies. Serum samples from 100 patients with CrD, 100 patients with UC, 129 patients assessed for various autoimmune diseases (vADs) and 50 control individuals were analyzed. Two immunofluorometric assays for the detection of IgG and IgA CUZD1-specific antibodies were developed. CUZD1 autoantibodies were detected in 12.5% (25/200) IBD patients, including 16% of patients with CrD and in 9% of patients with UC (CrD vs. UC, p<0.05), compared with 3.1% (4/129) patients suspected of having vADs (CrD vs. ADs, p<0.05; UC vs. ADs, p=0.08). CUZD1 autoantibody positivity was not found to be related to disease location, age of disease onset or disease phenotype. This is the first study to describe novel IgA and IgG CUZD1 autoantibody enzyme-linked immunosorbent assay. These immunoassays agree well with standard IIF techniques and can be utilized in multicenter studies to investigate the diagnostic and clinical utility of CUZD1 autoantibodies.

    Original languageEnglish
    Pages (from-to)1574-1581
    Number of pages8
    JournalClinical Chemistry and Laboratory Medicine
    Volume55
    Issue number10
    Early online date27 Mar 2017
    DOIs
    Publication statusPublished - 28 Aug 2017

    Fingerprint Dive into the research topics of 'Novel immunoassays for detection of CUZD1 autoantibodies in serum of patients with inflammatory bowel diseases'. Together they form a unique fingerprint.

    Cite this